Live Breaking News & Updates on Tisagenlecleucel

Stay updated with breaking news from Tisagenlecleucel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

NICE Recommends Tisagenlecleucel for Pediatric R/R B-ALL

The National Institute for Health and Care Excellence has recommended the use of tisagenlecleucel in pediatric B-cell acute lymphoblastic leukemia. ....

United-kingdom , Helen-knight , National-health-service , Cancer-drugs-fund , United-kingdom-national-institute-for-health , National-institute-for-health-care-excellence , National-institute , Care-excellence , Health-care , Pediatricb-cell-acute-lymphoblastic-leukemia , National-institute-for-health-and-care-excellence , Tisagenlecleucel

CAR T-cells as Third-line and Beyond Therapy for FL

Bijal Shah, MD, discusses recent data on CAR T-cell therapy as third-line and beyond treatment for FL. ....

Bijal-shah , Recent-updates , Follicular-lymphoma , Mantle-cell-lymphoma , Beyond-therapy , Fl , Cmcl , Cart-cell-therapy , Bendamustine , Zuma-5 , Axicabtagene-ciloleucel

Tisagenlecleucel Yields Durable Responses in R/R Follicular Lymphoma

Patients with relapsed/refractory follicular lymphoma experienced durable responses when treated with tisagenlecleucel (Kymriah) in the phase 2 ELARA study (NCT03568461), according to data presented at the 2023 ASH Annual Meeting. ....

Stephenj-schuster , Margarita-louis-dreyfus-professor , Chronic-lymphocytic-leukemia , Lymphoma-clinical-care , Cash , Tisagenlecleucel , Follicular-lymphoma , Elara-study , Relapsed-refractory-follicular-lymphoma , Kymriah ,

Study Examines Axi-Cel Use for Follicular Lymphoma Management

Researchers compared chimeric antigen receptor T-cell therapies axicabtagene ciloleucel (axi-cel) and tisagenlecleucel.
....

Cancer-management , Axicabtagene-ciloleucel , Axi-cel , Tisagenlecleucel , Follicular-lymphoma , Cd3zeta- , Zuma-5 , Car-t ,